Patents by Inventor Jonathan Cooper

Jonathan Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230037255
    Abstract: The present invention relates to compounds of formula (I) wherein Q is selected from O or S; R1 is a non-aromatic heterocyclic group comprising at least one ring nitrogen atom, wherein R1 is attached to the sulfur atom of the sulfonylurea group by a ring carbon atom, and wherein R1 may optionally be substituted; and R2 is a cyclic group substituted at the ?-position, wherein R2 may optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.
    Type: Application
    Filed: August 16, 2022
    Publication date: February 2, 2023
    Inventors: Matthew COOPER, David MILLER, Angus MACLEOD, Jimmy VAN WILTENBURG, Stephen THOM, Stephen ST-GALLAY, Jonathan SHANNON
  • Publication number: 20230018460
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Application
    Filed: November 19, 2020
    Publication date: January 19, 2023
    Inventors: Andrew Wilkinson, Ian Cooper, David Orr, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell, James Kirkham
  • Patent number: 11542255
    Abstract: The present invention relates to sulfonylureas and sulfonylthioureas comprising a 5-membered heteroaryl ring attached to the sulfonyl group, wherein the heteroaryl ring is di-substituted at the 3- and 4-positions relative to the point of attachment of the sulfonyl group, wherein at least one of the di-substituents contains a nitrogen atom. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: January 3, 2023
    Assignee: INFLAZOME LIMITED
    Inventors: Matthew Cooper, David Miller, Angus MacLeod, Stephen Thom, Stephen St-Gallay, Jonathan Shannon, Thomas Alanine, Stuart Onions, Ian Strutt
  • Publication number: 20220410060
    Abstract: A breather is disclosed. The breather may have a breather housing, a desiccant material, and a moisture indicator. The breather housing may be configured to receive at least an air flow containing moisture. The desiccant material may be contained within the breather housing, and the desiccant material may be enclosed by a breather wall. The moisture indicator may be located within the breather housing, and the moisture indicator may be positioned between the desiccant material and an internal side of the breather wall. The moisture indicator may provide a visible representation of an amount of moisture adsorbed by the desiccant breather. The visible representation of the moisture indicator may be visually observable through the breather wall. The desiccant material may be configured to adsorb up to about forty percent (40%) of the desiccant material's weight in moisture.
    Type: Application
    Filed: June 28, 2022
    Publication date: December 29, 2022
    Inventors: Olivia Willemsen, Eric Cooper Pride, Jay Michael Cooper, Jonathan Lee Haworth, Nikhil Rajkumar Gaikwad
  • Publication number: 20220389031
    Abstract: The present invention relates to macrocyclic compounds, such as macrocyclic sulfonyl amides. The present invention further relates to associated salts, solvates, prodrugs and pharmaceutical compositions, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.
    Type: Application
    Filed: August 13, 2020
    Publication date: December 8, 2022
    Inventors: Matthew COOPER, David MILLER, Angus MACLEOD, Stephen THOM, Jonathan SHANNON, Celia Amparo INCERTI-PRADILLOS, Christopher Gordon MCPHERSON
  • Patent number: 11507998
    Abstract: A computer system is provided that includes a paired list of data transaction requests on which a matching process is performed. There are multiple different types of data transaction requests that are stored in the paired list including data transaction requests with midpoint attributes and data transaction requests with discretion attributes. The computer system may determine how the multiple different types of data transaction requests may be match against each other. Two matching processes can be used to determine if a match exists between the first and second sides of the paired list. Matches that are determined at private values are not disseminated to third-parties via public market data feeds.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: November 22, 2022
    Assignee: NASDAQ, INC.
    Inventors: Joseph Noviello, Steven Cooper, Leo Golubovsky, Chung-Sin Wang, Jonathan Wakefield
  • Publication number: 20220350325
    Abstract: A component life prediction system configured to predict the remaining life of a consumable component installed on an aircraft. The system includes a processor configured to: receive wear information indicative of a current wear state of the component; receive schedule information indicative of a future flight schedule for the aircraft; and determine the remaining life of the component based on the received wear information and the received schedule information.
    Type: Application
    Filed: September 16, 2020
    Publication date: November 3, 2022
    Inventors: Jonathan COOPER, Matthew GADD
  • Patent number: 11465992
    Abstract: The present invention relates to compounds of formula (I): wherein Q is selected from O or S; R1 is a non-aromatic heterocyclic group comprising at least one ring nitrogen atom, wherein R1 is attached to the sulfur atom of the sulfonylurea group by a ring carbon atom, and wherein R1 may optionally be substituted; and R2 is a cyclic group substituted at the ?-position, wherein R2 may optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.
    Type: Grant
    Filed: July 4, 2018
    Date of Patent: October 11, 2022
    Assignee: INFLAZOME LIMITED
    Inventors: Matthew Cooper, David Miller, Angus MacLeod, Jimmy Van Wiltenburg, Stephen Thom, Stephen St-Gallay, Jonathan Shannon
  • Patent number: 11459296
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: October 4, 2022
    Assignee: INFEX Therapeutics Limited
    Inventors: Ian Cooper, David Orr, Andrew Wilkinson, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell
  • Publication number: 20220288329
    Abstract: A device is disclosed for the preparation of nebulised droplets, for inhalation. The device has: a surface acoustic wave (SAW) transmission surface; a SAW transducer adapted to generate and propagate SAWs along the SAW transmission surface; and an array of cavities opening at the SAW transmission surface for containing a liquid. In operation, SAWs propagating along the SAW transmission surface interact with the liquid in the cavities to produce nebulised droplets of the liquid. Operation of the device results in a nebulised plume of droplets of average diameter in the range 1-5 ?m.
    Type: Application
    Filed: April 1, 2022
    Publication date: September 15, 2022
    Inventors: Julien Reboud, Robert Wilson, Jonathan Cooper
  • Publication number: 20220289766
    Abstract: The present invention relates to macrocyclic compounds, such as macrocyclic sulfonyl ureas. The present invention further relates to associated salts, solvates, prodrugs and pharmaceutical compositions and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.
    Type: Application
    Filed: August 13, 2020
    Publication date: September 15, 2022
    Inventors: Matthew COOPER, David MILLER, Angus MACLEOD, Thomas ALANINE, Stephen THOM, Jonathan SHANNON, Jokin CARRILLO ARREGUI, Stephen ST-GALLAY
  • Publication number: 20220280919
    Abstract: The present invention relates to a NOx storage material comprising a cerium-based mixed oxide comprising cerium, oxygen, and a first rare earth metal other than cerium, wherein said NOx storage material further comprises a second rare earth metal other than cerium; wherein said first rare earth metal is different to said second rare earth metal; and wherein said second rare earth metal is disposed or supported on the surface of the cerium-based mixed oxide.
    Type: Application
    Filed: February 23, 2022
    Publication date: September 8, 2022
    Inventors: Yannick Bidal, Alba Castanon Rodriguez, Andrew Chiffey, Oliver Cooper, Jonathan Radcliffe
  • Patent number: 11370776
    Abstract: The present invention relates to compounds of formula (I): wherein Q is O or S, R1 is a 6-membered heteroaryl group containing at least one nitrogen atom in the 6-membered ring structure, wherein R1 may optionally be substituted, and R2 is a cyclic group substituted at the ?-position, wherein R2 may optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.
    Type: Grant
    Filed: July 4, 2018
    Date of Patent: June 28, 2022
    Assignee: INFLAZOME LIMITED
    Inventors: Matthew Cooper, David Miller, Angus Macleod, Jimmy Van Wiltenburg, Stephen Thom, Stephen St-Gallay, Jonathan Shannon
  • Patent number: 11342895
    Abstract: An audio system and method for modifying an audio playback including configuring an audio playback device, the audio playback device comprising a plurality of far-field audio inputs; generating the audio playback via the audio playback device; receiving, via at least one far-field audio input of the plurality of far-field audio inputs, a content-agnostic audio input from a first position within an environment; and, modifying the audio playback in response to the content-agnostic audio input.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: May 24, 2022
    Assignee: Bose Corporation
    Inventor: Jonathan Cooper
  • Patent number: 11311686
    Abstract: A device is disclosed for the preparation of nebulised droplets, for inhalation. The device has: a surface acoustic wave (SAW) transmission surface; a SAW transducer adapted to generate and propagate SAWs along the SAW transmission surface; and an array of cavities opening at the SAW transmission surface for containing a liquid. In operation, SAWs propagating along the SAW transmission surface interact with the liquid in the cavities to produce nebulised droplets of the liquid. Operation of the device results in a nebulised plume of droplets of average diameter in the range 1-5 ?m.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: April 26, 2022
    Assignee: The University Court of the University of Glasgow
    Inventors: Julien Reboud, Robert Wilson, Jonathan Cooper
  • Publication number: 20220098286
    Abstract: Neutralizing antibodies that specifically bind to HIV-1 Env and antigen binding fragments of these antibodies are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. Methods for detecting HIV-1 using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragment, nucleic acids and vectors to prevent and/or treat an HIV-1 infection is disclosed.
    Type: Application
    Filed: December 14, 2021
    Publication date: March 31, 2022
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Servic, The Trustees of Columbia University in the City of New York
    Inventors: Peter Kwong, Young Do Kwon, Ivelin Georgiev, Gilad Ofek, Baoshan Zhang, Krisha McKee, John Mascola, Mark Connors, Gwo-Yu Chuang, Sijy O'Dell, Robert Bailer, Mark Louder, Mangaiarkarasi Asokan, Richard Schwartz, Jonathan Cooper, Kevin Carlton, Michael Bender, Amarendra Pegu, Lawrence Shapiro, Tatyana Gindin, Lisa Kueltzo
  • Patent number: 11236152
    Abstract: Neutralizing antibodies that specifically bind to HIV-1 Env and antigen binding fragments of these antibodies are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. Methods for detecting HIV-1 using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragment, nucleic acids and vectors to prevent and/or treat an HIV-1 infection is disclosed.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: February 1, 2022
    Assignees: The United States of America, as represented by the Sectetary, Department of Health and Human Services, The Trustees of Columbia University in the City of New York
    Inventors: Peter Kwong, Young Do Kwon, Ivelin Georgiev, Gilad Ofek, Baoshan Zhang, Krisha McKee, John Mascola, Mark Connors, Gwo-Yu Chuang, Sijy O'Dell, Robert Bailer, Mark Louder, Mangaiarkarasi Asokan, Richard Schwartz, Jonathan Cooper, Kevin Carlton, Michael Bender, Amarendra Pegu, Lawrence Shapiro, Tatyana Gindin, Lisa Kueltzo
  • Patent number: 11203410
    Abstract: An aircraft is disclosed having a wing, the wing having a fixed wing with a wing tip device moveably mounted about a hinge at the tip thereof. The wing tip device is operable between a flight configuration, and a load alleviating configuration for load alleviation during flight. The aircraft includes a restraining assembly operable between a restraining mode in which the wing tip device is held in the flight configuration using a restraining force such as by a brake, and a releasing mode in which the restraining force on the wing tip device is released, such that the wing tip device may adopt the load alleviating configuration.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: December 21, 2021
    Assignee: AIRBUS OPERATIONS LIMITED
    Inventors: Thomas Wilson, Martin Herring, John Pattinson, Jonathan Cooper, Andrea Castrichini, Rafic Ajaj, Hitul Dhoru
  • Patent number: 11001365
    Abstract: An aircraft is disclosed having a wing, the wing having a fixed wing with a wing tip device moveably mounted about a hinge at the tip thereof. The wing tip device is operable between a flight configuration, and a load alleviating configuration for load alleviation during flight. The aircraft includes a restraining assembly operable between a restraining mode in which the wing tip device is held in the flight configuration using a restraining force such as by a brake, and a releasing mode in which the restraining force on the wing tip device is released, such that the wing tip device may adopt the load alleviating configuration.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: May 11, 2021
    Assignee: AIRBUS OPERATIONS LIMITED
    Inventors: Thomas Wilson, Martin Herring, John Pattinson, Jonathan Cooper, Andrea Castrichini, Rafic Ajaj, Hitul Dhoru
  • Publication number: 20210104992
    Abstract: An audio system and method for modifying an audio playback including configuring an audio playback device, the audio playback device comprising a plurality of far-field audio inputs; generating the audio playback via the audio playback device; receiving, via at least one far-field audio input of the plurality of far-field audio inputs, a content-agnostic audio input from a first position within an environment; and, modifying the audio playback in response to the content-agnostic audio input.
    Type: Application
    Filed: October 7, 2019
    Publication date: April 8, 2021
    Applicant: Bose Corporation
    Inventor: Jonathan Cooper